DAGLCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。DAGL遺伝子サイレンサーは、DAGL CRISPR/Cas9ノックアウトプラスミドとDAGLDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のDAGLCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
DAGL CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
DAGLα CRISPR/Cas9 KOプラスミド (h) | sc-402826 | h | Gene Knockout | GFP | 0 | ||
DAGLα CRISPR/Cas9 KOプラスミド (h2) | sc-402826-KO-2 | h | Gene Knockout | GFP | 0 | ||
DAGLα HDRプラスミド (h2) | sc-402826-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
DAGLα Double Nickaseプラスミド (h) | sc-402826-NIC | h | Gene Knockout | Puromycin | 0 | ||
DAGLα Double Nickaseプラスミド (h2) | sc-402826-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
DAGLα CRISPR/Cas9 KOプラスミド (m) | sc-435311 | m | Gene Knockout | GFP | 0 | ||
DAGLα HDRプラスミド (m) | sc-435311-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
DAGLα Double Nickaseプラスミド (m) | sc-435311-NIC | m | Gene Knockout | Puromycin | 0 | ||
DAGLα Double Nickaseプラスミド (m2) | sc-435311-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
DAGLβ CRISPR/Cas9 KOプラスミド (h) | sc-406084 | h | Gene Knockout | GFP | 0 | ||
DAGLβ HDRプラスミド (h) | sc-406084-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
DAGLβ Double Nickaseプラスミド (h) | sc-406084-NIC | h | Gene Knockout | Puromycin | 0 | ||
DAGLβ Double Nickaseプラスミド (h2) | sc-406084-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
DAGLβ CRISPR/Cas9 KOプラスミド (m) | sc-433118 | m | Gene Knockout | GFP | 0 | ||
DAGLβ HDRプラスミド (m) | sc-433118-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
DAGLβ Double Nickaseプラスミド (m) | sc-433118-NIC | m | Gene Knockout | Puromycin | 0 | ||
DAGLβ Double Nickaseプラスミド (m2) | sc-433118-NIC-2 | m | Gene Knockout | Puromycin | 0 |
DAGL CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
DAGLα CRISPR Activationプラスミド (h) | sc-402826-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAGLα CRISPR Activationプラスミド (h2) | sc-402826-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAGLα Lentiviral Activation Particles (h) | sc-402826-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAGLα Lentiviral Activation Particles (h2) | sc-402826-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAGLα CRISPR Activationプラスミド (m) | sc-435311-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAGLα CRISPR Activationプラスミド (m2) | sc-435311-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAGLα Lentiviral Activation Particles (m) | sc-435311-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAGLα Lentiviral Activation Particles (m2) | sc-435311-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAGLβ CRISPR Activationプラスミド (h) | sc-406084-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAGLβ CRISPR Activationプラスミド (h2) | sc-406084-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAGLβ Lentiviral Activation Particles (h) | sc-406084-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAGLβ Lentiviral Activation Particles (h2) | sc-406084-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAGLβ CRISPR Activationプラスミド (m) | sc-433118-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAGLβ CRISPR Activationプラスミド (m2) | sc-433118-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAGLβ Lentiviral Activation Particles (m) | sc-433118-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
DAGLβ Lentiviral Activation Particles (m2) | sc-433118-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |